Sera Prognostics (SERA) EBT Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | -2.99 Mn |
| Sep 30, 2025 | -143,824.00 |
| Jun 30, 2025 | -2.59 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | -843,506.00 |
| Sep 30, 2024 | 774,339.00 |
| Dec 31, 2023 | -181,928.00 |
| Sep 30, 2023 | -906,202.00 |
| Jun 30, 2023 | 201,654.00 |
| Mar 31, 2023 | 471,038.00 |
| Dec 31, 2022 | -317,148.00 |
| Sep 30, 2022 | 219,814.00 |
| Jun 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | -530,452.00 |
| Sep 30, 2021 | -615,587.00 |
| Jun 30, 2021 | 1.19 Mn |
| Mar 31, 2021 | 3.98 Mn |
| Dec 31, 2020 | 1.29 Mn |
| Sep 30, 2020 | -2.31 Mn |